For which superficial bacterial skin infections is fusidic acid cream 2% indicated, and what is the recommended application regimen?

Fusidic Acid Cream 2%: Indications and Application Regimen

Fusidic acid cream 2% is indicated for mild to moderately severe superficial bacterial skin infections caused primarily by Staphylococcus aureus, including impetigo, folliculitis, infected eczema, and infected traumatic wounds, applied 2-3 times daily for 7-14 days. 1, 2

Primary Indications

Fusidic acid cream 2% is specifically effective for:

• Impetigo - highly contagious superficial epidermal infection caused by β-hemolytic Streptococcus and/or S. aureus, particularly common in children 3, 1
• Folliculitis - superficial infection of hair follicles 1
• Infected atopic dermatitis/eczema - when staphylococcal secondary infection is suspected or confirmed 1, 4
• Infected traumatic wounds - superficial lacerations or abrasions with bacterial contamination 1
• Furunculosis - small, localized boils without extensive surrounding cellulitis 1
• Erythrasma - superficial bacterial skin infection 1

Application Regimen

• Apply fusidic acid 2% cream to the affected area 2-3 times daily 2, 5
• Treatment duration: 7-14 days depending on clinical response 2, 6
• The cream formulation is particularly suitable for weeping lesions or areas not requiring dry dressing 2
• For dry lesions requiring dressing coverage, fusidic acid ointment may be preferred over cream 2

Microbiological Activity

• Fusidic acid demonstrates potent activity against S. aureus (the most common skin pathogen), including methicillin-resistant strains (MRSA) 1, 4
• Also effective against other Gram-positive bacteria including Streptococcus species 1
• Resistance rates to fusidic acid remain stably low 4
• No cross-resistance with other antibiotics in routine clinical use 1

Important Limitations and When NOT to Use

Fusidic acid cream is NOT appropriate for:

• Simple abscesses or boils - incision and drainage is the primary treatment; antibiotics are not needed for simple, well-circumscribed abscesses 3
• Cellulitis or erysipelas - these deeper infections require systemic antibiotic therapy against Gram-positive bacteria 3
• Infections with systemic signs - presence of fever, hypotension, oliguria, or decreased mental alertness requires systemic antibiotics 3
• Extensive infections - hidradenitis suppurativa, chronic leg ulcers, burns, and pressure sores require systemic therapy 1
• Deep soft tissue infections - require systemic antibiotics 7
• Immunocompromised patients with significant infections - require systemic therapy 3

Combination Therapy Considerations

• Fusidic acid combined with topical corticosteroids (betamethasone or hydrocortisone) is extremely useful for infected atopic dermatitis/eczema where both antibacterial and anti-inflammatory effects are needed 1, 4
• The lipid-enriched cream formulation provides additional emollient and moisturizing benefits, particularly valuable in atopic-infected eczema 4

Clinical Efficacy

• Bacteriologic cure rates of 87-97% have been demonstrated in clinical trials 6
• Clinical cure or significant improvement achieved in 94-97% of patients with superficial skin infections 6
• Comparable efficacy to mupirocin for superficial infections, though recent evidence suggests fusidic acid may have superior activity against Propionibacterium acnes 5, 6

Safety Profile

• Well tolerated with minimal adverse reactions 2, 6
• No steroid activity despite steroid-like molecular structure 1
• No cross-allergy with other antibiotics 1
• High skin penetration due to molecular structure 1